CAS 170098-38-1
:Alvimopan dihydrate
Description:
Alvimopan dihydrate is a pharmaceutical compound primarily used as a peripherally acting mu-opioid receptor antagonist. It is designed to mitigate the gastrointestinal side effects associated with opioid analgesics, particularly postoperative ileus. The substance is characterized by its molecular structure, which includes a specific arrangement of atoms that allows it to selectively block mu-opioid receptors in the gastrointestinal tract without affecting central nervous system receptors. This selectivity helps to maintain analgesic effects while reducing the risk of constipation. Alvimopan dihydrate is typically administered orally and is known for its rapid absorption and elimination. The dihydrate form indicates the presence of water molecules in its crystalline structure, which can influence its solubility and stability. In clinical settings, it is often utilized in patients undergoing bowel resection surgeries to promote gastrointestinal recovery. As with any medication, it is essential to consider potential side effects and contraindications, particularly in patients with certain medical conditions or those taking other medications.
Formula:C25H32N2O4·2H2O
InChI:InChI=1S/C25H32N2O4.2H2O/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19;;/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30);2*1H2/t18-,20-,25+;;/m0../s1
InChI key:InChIKey=USPVLEIQIUNQGE-DBFLIVQGSA-N
SMILES:C[C@@]1([C@@H](C)CN(C[C@H](CC2=CC=CC=C2)C(NCC(O)=O)=O)CC1)C3=CC(O)=CC=C3.O
Synonyms:- 2-([(2S)-2-([(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl)-3-phenylpropanoyl]amino)acetic acid dihydrate
- 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate
- ADL 8-2698 dihydrate
- Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, dihydrate
- Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, hydrate (1:2)
- Glycine, N-[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, dihydrate, [3R-[1(S*),3α,4α]]-
- LY 246736 dihydrate
- N-{(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl}glycine dihydrate
- [[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid dihydrate
- Alvimopan dihydrate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Glycine,N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, dihydrate
CAS:Formula:C25H36N2O6Purity:98%Color and Shape:SolidMolecular weight:460.5631Alvimopan Dihydrate
CAS:Formula:C25H32N2O4·2H2OPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:460.57Alvimopan Dihydrate
CAS:Controlled ProductFormula:C25H32N2O4H2OColor and Shape:NeatMolecular weight:460.56Alvimopan dihydrate (LY246736 dihydrate)
CAS:Alvimopan dihydrate is a potent, oral μ-opioid receptor blocker (IC50 1.7 nM, Ki 0.47 nM) used in postoperative ileus research.Formula:C25H36N2O6Color and Shape:SolidMolecular weight:460.56





